Home » Diasorin swerves to -5%, to KO the stock is Pfizer’s Covid pill

Diasorin swerves to -5%, to KO the stock is Pfizer’s Covid pill

by admin
  1. Home ››
  2. News >>
  3. News Italy ››


FACEBOOK
TWITTER
LINKEDIN

Strong acceleration to the downside in the afternoon for Diasorin, who lost more than 5% to 183 euros. Diasorin, a leader in the production of diagnostic tests, pays for today’s newsflow from overseas with Pfizer announcing that its Covid-19 pill can reduce the risk of being hospitalized or dying by 89% if taken within three days of developing the symptoms. The Pfizer pill, if approved by regulators, has the potential to “save patients’ lives, reduce the severity of COVID-19 infections and eliminate up to nine out of ten hospitalizations,” Pfizer’s CEO noted.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy